Document is current
Any future updates will be listed below
-
Authors
Wallwiener, Markus
Nabieva, Naiba
Feisst, Manuel
Fehm, Tanja
de Waal, Johann
Rezai, Mahdi
Baier, Bernd
Baake, Gerold
Kolberg, Hans-Christian
Guggenberger, Martin
Warm, Mathias
Harbeck, Nadia
Wuerstlein, Rachel
Deuker, Jörg-Uwe
Dall, Peter
Richter, Barbara
Wachsmann, Grischa
Brucker, Cosima
Siebers, Jan Willem
Popovic, Milos
Kuhn, Thomas
Wolf, Christopher
Vollert, Hans-Walter
Breitbach, Georg-Peter
Janni, Wolfgang
Landthaler, Robert
Kohls, Andreas
Rezek, Daniela
Noesselt, Thomas
Fischer, Gunnar
Henschen, Stephan
Praetz, Thomas
Heyl, Volker
Kühn, Thorsten
Krauss, Thomas
Thomssen, Christoph
Hohn, Andre
Tesch, Hans
Mundhenke, Christoph
Hein, Alexander
Rauh, Claudia
Bayer, Christian M.
Schmidt, Katja
Belleville, Erik
Brucker, Sara Y.
Hadji, Peyman
Beckmann, Matthias W.
Wallwiener, Diethelm
Kümmel, Sherko
Hartkopf, Andreas
Fasching, Peter A. https://orcid.org/0000-0003-4885-8471
-
Funding
Funding for this research was provided by:
Novartis Pharma (not applicable)
- License Information
-
More Information
Article History
Received: 12 May 2018
Accepted: 6 June 2019
First Online: 21 June 2019
Ethics approval and consent to participate
: All patients provided written informed consent, and the study was approved by the Ethics Committee of the Medical Faculty of Friedrich Alexander University of Erlangen–Nuremberg.
: Not applicable.
: N.N. has received honoraria from Janssen-Cilag and Novartis. P.H. has received speakers fee from Amgen, Novartis, Pfizer, Elli and Lilly. P.A.F. has received honoraria from Pfizer, Novartis, Roche, TEVA and Celgene. H.C.K. has received honoraria from Carl Zeiss meditec, TEVA, Theraclion, Novartis, Amgen, AstraZeneca, Pfizer, Janssen-Cilag, GSK, LIV Pharma, Roche and Genomic Health. T.K. has received consultancy honoraria. W.J. has received honoraria and research grants from Novartis. S. Kü. has received honoraria from Novartis, Pfizer and AstraZeneca. H.T. has received honoraria from Novartis. C.T. has received honoraria from Amgen, AstraZeneca, Celgene, GenomicHealth, Lilly, Nanostring, Novartis, Pfizer, Puma, Roche. R.W. has received honoraria from Novartis, Pfizer, Lilly, AstraZeneca, Roche, Celgene, MSD, TEVA, HEXAL, Eisai, Tesaro Bio, Genomic Health, Agendia and Nanostring. E.B. has received honoraria from Novartis and Riemser. S.Y.B. has received consultancy honoraria from Department of Women’s Health/Research Centre for Women’s Health, Tuebingen University. M.W.B.’s institution has received research grants from Novartis. K.S. is employee of Novartis Pharma.All of the remaining authors have declared that they have no conflicts of interest.
